Comparison of New Combination Inhaler (FlutiForm HFA MDI 100/10 µg) Versus Fluticasone and Formoterol Administered Alone, and Placebo, in Patients With Asthma

NCT00393991 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

475

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: Fluticasone propionate/formoterol fumarate 100/10
DRUG: Fluticasone propionate 100
DRUG: Formoterol fumarate 10
DRUG: Placebo

Sponsor

SkyePharma AG